Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
2.375 USD
-2.66%
Updated:
Apr 18, 2024
Section:
Relative Value
The Relative Value of one
ADPT
stock under the Base Case scenario is
8.571
USD.
Compared to the current market price of 2.375 USD,
Adaptive Biotechnologies Corp
is
Undervalued by 72%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ADPT
Relative Value
Base Case
8.571
USD
Undervaluation 72%
Valuation Multiples
Multiples Across Competitors
ADPT Competitors Multiples
Adaptive Biotechnologies Corp Competitors
Adaptive Biotechnologies Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
339.5m USD | 2 | -1.5 | 0 | 0 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
209.8B USD | 4.9 | 35 | 21.7 | 31.8 | |
| US |
|
Danaher Corp
NYSE:DHR
|
175.2B USD | 7.3 | 36.9 | 25 | 35.2 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.6B USD | 2.8 | 30.6 | 16.6 | 25.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
56.2T KRW | 15.2 | 65.6 | 34.6 | 49.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37B CHF | 5.5 | 56.6 | 19.5 | 28.5 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
39.2B USD | 5.8 | 31.7 | 25.4 | 30.5 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
27.9B USD | 9.4 | 46.9 | 32.1 | 38.4 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.8B USD | 6.8 | 32.7 | 22.9 | 25.5 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
24.4B USD | 3 | 39.8 | 17 | 26.5 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
19.3B EUR | 7 | 62.4 | 32.2 | 48.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
